BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 12911637)

  • 1. Dysfunction of mitochondrial complex I and the proteasome: interactions between two biochemical deficits in a cellular model of Parkinson's disease.
    Höglinger GU; Carrard G; Michel PP; Medja F; Lombès A; Ruberg M; Friguet B; Hirsch EC
    J Neurochem; 2003 Sep; 86(5):1297-307. PubMed ID: 12911637
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mitochondrial complex inhibitors preferentially damage substantia nigra dopamine neurons in rat brain slices.
    Bywood PT; Johnson SM
    Exp Neurol; 2003 Jan; 179(1):47-59. PubMed ID: 12504867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered glial function causes neuronal death and increases neuronal susceptibility to 1-methyl-4-phenylpyridinium- and 6-hydroxydopamine-induced toxicity in astrocytic/ventral mesencephalic co-cultures.
    McNaught KS; Jenner P
    J Neurochem; 1999 Dec; 73(6):2469-76. PubMed ID: 10582607
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of proteasome inhibitor on cultured mesencephalic dopaminergic neurons.
    Kikuchi S; Shinpo K; Tsuji S; Takeuchi M; Yamagishi S; Makita Z; Niino M; Yabe I; Tashiro K
    Brain Res; 2003 Feb; 964(2):228-36. PubMed ID: 12576183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mitochondrial complex I inhibitor annonacin is toxic to mesencephalic dopaminergic neurons by impairment of energy metabolism.
    Lannuzel A; Michel PP; Höglinger GU; Champy P; Jousset A; Medja F; Lombès A; Darios F; Gleye C; Laurens A; Hocquemiller R; Hirsch EC; Ruberg M
    Neuroscience; 2003; 121(2):287-96. PubMed ID: 14521988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroscience. Pesticide causes Parkinson's in rats.
    Helmuth L
    Science; 2000 Nov; 290(5494):1068. PubMed ID: 11184997
    [No Abstract]   [Full Text] [Related]  

  • 7. Energy status, ubiquitin proteasomal function, and oxidative stress during chronic and acute complex I inhibition with rotenone in mesencephalic cultures.
    Zeevalk GD; Bernard LP
    Antioxid Redox Signal; 2005; 7(5-6):662-72. PubMed ID: 15890011
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism.
    Storch A; Kaftan A; Burkhardt K; Schwarz J
    Brain Res; 2000 Feb; 855(1):67-75. PubMed ID: 10650131
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanism of toxicity in rotenone models of Parkinson's disease.
    Sherer TB; Betarbet R; Testa CM; Seo BB; Richardson JR; Kim JH; Miller GW; Yagi T; Matsuno-Yagi A; Greenamyre JT
    J Neurosci; 2003 Nov; 23(34):10756-64. PubMed ID: 14645467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteasome mediates dopaminergic neuronal degeneration, and its inhibition causes alpha-synuclein inclusions.
    Sawada H; Kohno R; Kihara T; Izumi Y; Sakka N; Ibi M; Nakanishi M; Nakamizo T; Yamakawa K; Shibasaki H; Yamamoto N; Akaike A; Inden M; Kitamura Y; Taniguchi T; Shimohama S
    J Biol Chem; 2004 Mar; 279(11):10710-9. PubMed ID: 14672949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine oxidation facilitates rotenone-dependent potentiation of N-methyl-D-aspartate currents in rat substantia nigra dopamine neurons.
    Wu YN; Johnson SW
    Neuroscience; 2011 Nov; 195():138-44. PubMed ID: 21884756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An inhibitor of mitochondrial complex I, rotenone, inactivates proteasome by oxidative modification and induces aggregation of oxidized proteins in SH-SY5Y cells.
    Shamoto-Nagai M; Maruyama W; Kato Y; Isobe K; Tanaka M; Naoi M; Osawa T
    J Neurosci Res; 2003 Nov; 74(4):589-97. PubMed ID: 14598303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The selective toxicity of 1-methyl-4-phenylpyridinium to dopaminergic neurons: the role of mitochondrial complex I and reactive oxygen species revisited.
    Nakamura K; Bindokas VP; Marks JD; Wright DA; Frim DM; Miller RJ; Kang UJ
    Mol Pharmacol; 2000 Aug; 58(2):271-8. PubMed ID: 10908294
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretreatment with near-infrared light via light-emitting diode provides added benefit against rotenone- and MPP+-induced neurotoxicity.
    Ying R; Liang HL; Whelan HT; Eells JT; Wong-Riley MT
    Brain Res; 2008 Dec; 1243():167-73. PubMed ID: 18848925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quercetin up-regulates mitochondrial complex-I activity to protect against programmed cell death in rotenone model of Parkinson's disease in rats.
    Karuppagounder SS; Madathil SK; Pandey M; Haobam R; Rajamma U; Mohanakumar KP
    Neuroscience; 2013 Apr; 236():136-48. PubMed ID: 23357119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NMDA antagonists exacerbate neuronal death caused by proteasome inhibition in cultured cortical and striatal neurons.
    Snider BJ; Tee LY; Canzoniero LM; Babcock DJ; Choi DW
    Eur J Neurosci; 2002 Feb; 15(3):419-28. PubMed ID: 11876769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Near-infrared light via light-emitting diode treatment is therapeutic against rotenone- and 1-methyl-4-phenylpyridinium ion-induced neurotoxicity.
    Liang HL; Whelan HT; Eells JT; Wong-Riley MT
    Neuroscience; 2008 Jun; 153(4):963-74. PubMed ID: 18440709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lamotrigine inhibition of rotenone- or 1-methyl-4-phenylpyridinium-induced mitochondrial damage and cell death.
    Kim YJ; Ko HH; Han ES; Lee CS
    Brain Res Bull; 2007 Mar; 71(6):633-40. PubMed ID: 17292807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The parkinsonism-inducing drug 1-methyl-4-phenylpyridinium triggers intracellular dopamine oxidation. A novel mechanism of toxicity.
    Lotharius J; O'Malley KL
    J Biol Chem; 2000 Dec; 275(49):38581-8. PubMed ID: 10969076
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation.
    Fonck C; Baudry M
    Brain Res; 2001 Jun; 905(1-2):199-206. PubMed ID: 11423095
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.